Notice2023-05638
Board of Scientific Counselors, National Center for Injury Prevention and Control
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
March 20, 2023
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Abstract
In accordance with regulatory provisions, the Centers for Disease Control and Prevention (CDC) announces the following meeting for the Board of Scientific Counselors, National Center for Injury Prevention and Control (BSC, NCIPC or Board). This meeting is partially open to the public.
Full Text
<html>
<head>
<title>Federal Register, Volume 88 Issue 53 (Monday, March 20, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 53 (Monday, March 20, 2023)]
[Notices]
[Page 16634]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-05638]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Board of Scientific Counselors, National Center for Injury
Prevention and Control
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with regulatory provisions, the Centers for
Disease Control and Prevention (CDC) announces the following meeting
for the Board of Scientific Counselors, National Center for Injury
Prevention and Control (BSC, NCIPC or Board). This meeting is partially
open to the public.
DATES: The meeting will be held on May 3, 2023, from 1 p.m. to 3 p.m.,
EDT (CLOSED); and May 4, 2023, from 9:30 a.m. to 3:30 p.m., EDT (OPEN).
The public comment period will be at the end of the open session of the
meeting on May 4, 2023, from 3:10 p.m. to 3:25 p.m., EDT.
ADDRESSES: Webinar, Atlanta, Georgia. All participants must register by
using the following link to attend the open session: <a href="https://cdc.zoomgov.com/meeting/register/vJIsfuqtrT4pE4H6-oCKSs9t2KHS69o3yHo">https://cdc.zoomgov.com/meeting/register/vJIsfuqtrT4pE4H6-oCKSs9t2KHS69o3yHo</a>.
FOR FURTHER INFORMATION CONTACT: Christopher R. Harper, Ph.D., Senior
Epidemiologist, National Center for Injury Prevention and Control,
Centers for Disease Control and Prevention, 4770 Buford Highway NE,
Mailstop S-1069, Atlanta, Georgia 30341. Telephone: (404) 718-8330;
Email: <a href="/cdn-cgi/l/email-protection#b1dfd2d8c1d2d3c2d2f1d2d5d29fd6dec7"><span class="__cf_email__" data-cfemail="533d303a2330312030133037307d343c25">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: Portions of the meeting referenced above
will be closed to the public in accordance with provisions set forth in
section 552b(c)(4) and (6), title 5 U.S.C., and the Determination of
the Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, CDC, pursuant to Public Law 92-463 (5 U.S.C. 1009),
as amended.
Purpose: The Board of Scientific Counselors, National Center for
Injury Prevention and Control (BSC, NCIPC or Board) will: (1) conduct,
encourage, cooperate with, and assist other appropriate public health
authorities, scientific institutions, and scientists in the conduct of
research, investigations, experiments, demonstrations, and studies
relating to the causes, diagnosis, treatment, control, and prevention
of physical and mental diseases, and other impairments; (2) assist
States and their political subdivisions in preventing and suppressing
communicable and non-communicable diseases and other preventable
conditions and in promoting health and well-being; and (3) conduct and
assist in research and control activities related to injury. The BSC,
NCIPC makes recommendations regarding policies, strategies, objectives,
and priorities; reviews progress toward injury prevention goals; and
provides evidence in injury prevention-related research and programs.
The Board also provides advice on the appropriate balance of intramural
and extramural research, as well as the structure, progress, and
performance of intramural programs. The Board provides guidance on
extramural scientific program matters, including the: (1) review of
extramural research concepts for funding opportunity announcements; (2)
conduct of Secondary Peer Review of extramural research grant
applications, cooperative agreement applications, and contract
applications received in response to funding opportunity announcements
as they relate to the Center's programmatic balance and mission; (3)
submission of secondary review recommendations to the Center Director
of applications to be considered for funding support; (4) review of
research portfolios; and (5) review of program proposals.
Matters To Be Considered: The closed session of the meeting (Day 1)
will focus on the Secondary Peer Review of extramural research grant
applications received in response to two (2) Notices of Funding
Opportunity: RFA-CE-20-001--``Evaluating Practice-based Programs,
Policies, and Practices from CDC's Rape Prevention and Education (RPE)
Program: Expanding the Evidence to Prevent Sexual Violence (U01)''; and
RFA-CE-23-008--``Research Grants to Develop and Validate a Prognostic
Tool of Mental Health Sequelae After Traumatic Brain Injury for
Adolescent Patients'' (U01).'' The open session of the meeting (Day 2)
will include discussions on Improving the Quality and Reach of
Extramural Research Notices of Funding Opportunity; Updated and
Expanded CDC Guidance for the Identification and Response of Suicide
Clusters; Developing a Cascade of Care Framework and Surveillance
Indicators to Measure Linkage and Retention to Care for Substance Use
Disorders; and Moving Science and Data to Violence Prevention Action.
Agenda items are subject to change as priorities dictate.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2023-05638 Filed 3-17-23; 8:45 am]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on March 20, 2023.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.